BioCryst Pharmaceuticals, Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending September 30, 2022 was $-42.5 Million (a -27.76% decrease compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 139.16%
  • Annual Consolidated Net Income/Loss for 2021 was $-184 Million (a 0.68% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-183 Million (a 67.88% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2019 was $-109 Million (a 7.55% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending September 30, 2022 was $-193 Million (a -7.77% decrease compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss increased by 5.05% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-193 Million $-210 Million $-194 Million $-184 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of BioCryst Pharmaceuticals, Inc.

Most recent Consolidated Net Income/Lossof BCRX including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-42.52 $-58.86 $-74.2
2021 $-17.78 $-58.8 $-43.2 $-64.28 $-184.06
2020 $-60.49 $-46.12 $-38.61 $-37.6 $-182.81
2019 $-2.62 $-37.59 $-37.63 $-31.05 $-108.9
2018 $-27.43 $-29.6 $-18.45 $-25.78 $-101.25
2017 $-19.54 $-15.13 $-16.89 $-14.22 $-65.78
2016 $-4.5 $-11.53 $-16.28 $-22.83 $-55.14
2015 $-18.14 $-14.62 $4.9 $-15.16 $-43.02
2014 $-11.67 $-8.73 $-14.65 $-10.14 $-45.19
2013 $-5.43 $-8.0 $-12.17 $-4.51 $-30.11
2012 $-11.05 $-9.7 $-12.28 $-6.05 $-39.08

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology